{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:30:29Z","timestamp":1790767829709,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":374,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1111\/ajt.16747","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T05:36:01Z","timestamp":1625204161000},"page":"3734-3742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Outcomes of short-duration antiviral prophylaxis for hepatitis C positive donor kidney transplants"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1919-1970","authenticated-orcid":false,"given":"Gaurav","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idris","family":"Yakubu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Ijioma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Shinbashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6816-9297","authenticated-orcid":false,"given":"Dhiren","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0154-2261","authenticated-orcid":false,"given":"Irfan","family":"Moinuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layla","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4333-5551","authenticated-orcid":false,"given":"Chandra","family":"Bhati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3320-0493","authenticated-orcid":false,"given":"Marlon","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Cotterell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1111\/ajt.16747_bib1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.7326\/M17-2451","article-title":"The drug overdose epidemic and deceased-donor transplantation in the United States: a national registry study","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med."},{"issue":"6","key":"10.1111\/ajt.16747_bib2","doi-asserted-by":"crossref","first-page":"e0233927","DOI":"10.1371\/journal.pone.0233927","article-title":"High prevalence of injection drug use and blood-borne viral infections among patients in an urban emergency department","volume":"15","author":"Anderson","year":"2020","journal-title":"PLoS ONE."},{"issue":"1","key":"10.1111\/ajt.16747_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13011-020-00306-1","article-title":"Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and meta-analysis","volume":"15","author":"Karimi","year":"2020","journal-title":"Substance Abuse Treatment, Prevent, Policy."},{"issue":"24","key":"10.1111\/ajt.16747_bib4","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients","volume":"376","author":"Goldberg","year":"2017","journal-title":"New Engl J Med."},{"issue":"8","key":"10.1111\/ajt.16747_bib5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M17-2871","article-title":"Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: an open-label nonrandomized trial","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med."},{"issue":"7","key":"10.1111\/ajt.16747_bib6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/tri.13410","article-title":"Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study","volume":"32","author":"Franco","year":"2019","journal-title":"Transpl Int."},{"issue":"11","key":"10.1111\/ajt.16747_bib7","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1681\/ASN.2020050686","article-title":"Multicenter study to transplant hepatitis C-infected kidneys (MYTHIC): an open-label study of combined glecaprevir and pibrentasvir to treat recipients of transplanted kidneys from deceased donors with hepatitis C virus infection","volume":"31","author":"Sise","year":"2020","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"10.1111\/ajt.16747_bib8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.kint.2017.10.024","article-title":"Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient","volume":"93","author":"Chute","year":"2018","journal-title":"Kidney Int."},{"issue":"2","key":"10.1111\/ajt.16747_bib9","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/ajt.15583","article-title":"Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: a unique complication in the DAA era","volume":"20","author":"Kapila","year":"2020","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.16747_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.31011","article-title":"Hepatitis C virus NAT-positive solid organ allografts transplanted into hepatitis C virus-negative recipients: a real-world experience","volume":"72","author":"Kapila","year":"2020","journal-title":"Hepatol."},{"issue":"11","key":"10.1111\/ajt.16747_bib11","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1111\/ajt.15530","article-title":"Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: single center experience","volume":"19","author":"Molnar","year":"2019","journal-title":"Am J Transplant."},{"issue":"6","key":"10.1111\/ajt.16747_bib12","doi-asserted-by":"crossref","first-page":"ofy076","DOI":"10.1093\/ofid\/ofy076","article-title":"Absolute insurer denial of direct-acting antiviral therapy for hepatitis C: a national specialty pharmacy cohort study","volume":"5","author":"Gowda","year":"2018","journal-title":"Open Forum Infect Dis."},{"issue":"5","key":"10.1111\/ajt.16747_bib13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jhep.2018.06.016","article-title":"The removal of DAA restrictions in Europe \u2013 one step closer to eliminating HCV as a major public health threat","volume":"69","author":"Marshall","year":"2018","journal-title":"J Hepatol."},{"issue":"6","key":"10.1111\/ajt.16747_bib14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/cpdd.671","article-title":"Drug-drug interactions of tacrolimus or cyclosporine with glecaprevir and pibrentasvir in healthy subjects","volume":"8","author":"Kosloski","year":"2019","journal-title":"Clin Pharmacol Drug Develop."},{"issue":"4","key":"10.1111\/ajt.16747_bib15","first-page":"327","article-title":"Efficacy and safety of direct-acting antivirals in hepatitis C virus-infected patients taking proton pump inhibitors","volume":"5","author":"Wijarnpreecha","year":"2017","journal-title":"J Clin Transl Hepatol."},{"issue":"Suppl 1","key":"10.1111\/ajt.16747_bib16","first-page":"S22","article-title":"Pharmacokinetics and drug interactions of medications used to treat hepatitis C virus infection in the setting of chronic kidney disease and kidney transplantation","volume":"22","author":"Ortiz","year":"2018","journal-title":"Hemodial Internat."},{"issue":"17","key":"10.1111\/ajt.16747_bib17","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-infected donors to uninfected recipients","volume":"380","author":"Woolley","year":"2019","journal-title":"New Engl J Med."},{"issue":"7","key":"10.1111\/ajt.16747_bib18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S2468-1253(20)30081-9","article-title":"Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study","volume":"5","author":"Feld","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"2","key":"10.1111\/ajt.16747_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"Sainz","year":"2012","journal-title":"Nat Med."},{"issue":"3","key":"10.1111\/ajt.16747_bib20","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/ajt.15664","article-title":"Ultra-short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients","volume":"20","author":"Gupta","year":"2020","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.16747_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.12659\/AOT.905428","article-title":"Is kidney donor profile index (KDPI) valid for hepatitis C aviremic kidneys?","volume":"22","author":"Sibulesky","year":"2017","journal-title":"Annals Transplant."},{"issue":"8","key":"10.1111\/ajt.16747_bib22","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/ajt.12761","article-title":"External validation of the estimated posttransplant survival score for allocation of deceased donor kidneys in the United States","volume":"14","author":"Clayton","year":"2014","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.16747_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/M18-0749","article-title":"Twelve-month outcomes after transplant of hepatitis C-infected kidneys into uninfected recipients: a single-group trial","volume":"169","author":"Reese","year":"2018","journal-title":"Ann Intern Med."},{"issue":"1","key":"10.1111\/ajt.16747_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M20-1468","article-title":"Four-week direct-acting antiviral prophylaxis for kidney transplantation from hepatitis C-viremic donors to hepatitis C-negative recipients: an open-label nonrandomized study","volume":"174","author":"Durand","year":"2020","journal-title":"Ann Intern Med."},{"issue":"11","key":"10.1111\/ajt.16747_bib25","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s40262-016-0397-0","article-title":"Clinical pharmacokinetics and pharmacodynamics of ledipasvir\/sofosbuvir, a fixed-dose combination tablet for the treatment of hepatitis C","volume":"55","author":"German","year":"2016","journal-title":"Clin Pharmacokinet."},{"issue":"10","key":"10.1111\/ajt.16747_bib26","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s40262-019-00774-0","article-title":"Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations: a 2019 update","volume":"58","author":"Smolders","year":"2019","journal-title":"Clin Pharmacokinet."},{"issue":"8","key":"10.1111\/ajt.16747_bib27","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1124\/dmd.117.079038","article-title":"The drug-drug interaction potential of antiviral agents for the treatment of chronic hepatitis C infection","volume":"46","author":"Garrison","year":"2018","journal-title":"Drug metabolism and disposition: the biological fate of chemicals."},{"issue":"3","key":"10.1111\/ajt.16747_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2018.07.003","article-title":"Efficacy and pharmacokinetics of glecaprevir and pibrentasvir with concurrent use of acid-reducing agents in patients with chronic HCV infection","volume":"17","author":"Flamm","year":"2019","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1111\/ajt.16747_bib29","unstructured":"A guide to calculating and interpreting the Estimated Post-Transplant Survival (EPTS) score used in the Kidney Allocation System (KAS). https:\/\/optn.transplant.hrsa.gov\/media\/1511\/guide_to_calculating_interpreting_epts.pdf. 2020. Accessed September 1, 2020."},{"key":"10.1111\/ajt.16747_bib30","doi-asserted-by":"crossref","first-page":"e14068","DOI":"10.1111\/ctr.14068","article-title":"A Simple risk based reimbursement system for kidney transplant","volume":"35","author":"Schwantes","year":"2020","journal-title":"Clin Transplant."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16747","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.16747","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522088050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522088050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:33:18Z","timestamp":1761629598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522088050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1600613522088050"],"URL":"https:\/\/doi.org\/10.1111\/ajt.16747","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of short-duration antiviral prophylaxis for hepatitis C positive donor kidney transplants","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.16747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}